Register for Newsletter

Startup

Excelsior Sciences raises $95 million for drug discovery with AI-ready chemistry
Excelsior Sciences raises $95 million for drug discovery with AI-ready chemistry
EIB, Angelini Ventures team up to pump €150 million into European biotech, digital health startups
EIB, Angelini Ventures team up to pump €150 million into European biotech, digital health startups
Teva launches 'Teva Rise' to harness global innovation and transform healthcare
Teva launches 'Teva Rise' to harness global innovation and transform healthcare
View More

Digitization

Accenture invests in Ryght AI to revolutionize clinical trials
Accenture invests in Ryght AI to revolutionize clinical trials
Grace and Molecule.one strike multi-year AI pact to break peptide manufacturing bottlenecks
Grace and Molecule.one strike multi-year AI pact to break peptide manufacturing bottlenecks
Avandra Health acquires DatCard and Sorna to build industry-leading medical imaging platform
Avandra Health acquires DatCard and Sorna to build industry-leading medical imaging platform
View More

Latest Stories

FDA nod to first oral single-dose treatment for gonorrhea

ImmunityBio’s ANKTIVA wins EMA nod for early EU approval in hard-to-treat bladder cancer

Accenture invests in Ryght AI to revolutionize clinical trials

FDA accepts Sentynl Therapeutics CUTX-101 NDA resubmission

Ind-Swift Laboratories receives GMP compliance certificate from NNGYK-Hungary

Opinion
Metal-free catalysis is transforming future of sustainable pharmaceutical innovation
Metal-free catalysis is transforming future of sustainable pharmaceutical innovation
From Policy to Practice: How India’s Pharmaceutical Industry is Being Shaped by the PLI Scheme – by Vikram Aditya Sehgal, Director – Finance, Centrient India
From Policy to Practice: How India’s Pharmaceutical Industry is Being Shaped by the PLI Scheme – by Vikram Aditya Sehgal, Director – Finance, Centrient India

Interviews
Only 4-5 Indian pharma companies have a strong presence in Russia, opportunity is far bigger now: Manish Kumar, Vice-Chairman, Moscow Chamber of Commerce, Indian Commission; and President, Soltex Group
Only 4-5 Indian pharma companies have a strong presence in Russia, opportunity is far bigger now: Manish Kumar, Vice-Chairman, Moscow Chamber of Commerce, Indian Commission; and President, Soltex Group
Only 4-5 Indian pharma companies have a strong presence in Russia but the opportunity is far bigger now: Manish Kumar, Vice-Chairman, Moscow Chamber of Commerce, Indian Commission; and President, Soltex Group
Only 4-5 Indian pharma companies have a strong presence in Russia but the opportunity is far bigger now: Manish Kumar, Vice-Chairman, Moscow Chamber of Commerce, Indian Commission; and President, Soltex Group
Companies must shift from L1 costing to Life Cycle Cost Analysis: Abhilash Pasham, Associate GM - Central Engineering & Projects, Dr. Reddy's Laboratories
Companies must shift from L1 costing to Life Cycle Cost Analysis: Abhilash Pasham, Associate GM - Central Engineering & Projects, Dr. Reddy's Laboratories

Packaging